Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
Rauscher Disappointed In CREG Progress
Cancer Commission Surveying for Pill, Hepatoma Association
President Accepts Rauscher Resignation
NCI Urged To Back Ultrasounds Studies
Schmidt Attempted To Answer Critics
Trending Stories
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years
- After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.” - Trump administration announces “major crackdown” on healthcare fraud









